Helen Monaghan

About Helen Monaghan

Head of Clinical Trial Partnerships

  • Adjunct Senior Lecturer position at UNSW
  • BSc (Hons)

Helen is Head of Clinical Trial Partnerships for The George Institute Australia and holds an Adjunct Senior Lecturer position at UNSW.

She has more than 25 years of experience working on academic investigator-initiated clinical trials at the Yorkshire Clinical Trials Unit, Clinical Trial Service Unit at the University of Oxford and Imperial College, all in the UK.

Helen joined The George Institute in September 2000 as Senior Project Manager on the landmark ADVANCE trial and post-trial observational ADVANCE-ON study.

Helen has worked on many multicentre clinical trials, and in this role works to strengthen The George Institute’s clinical trial partnerships across Australia.

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease

JAMA Date published:

Hematuria Remission and Prognosis in IgA Nephropathy: A Post hoc Analysis of The TESTING Randomized Clinical Trial

American Journal of Kidney Diseases Date published:

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

American Journal of Nephrology Date published:

A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy

Kidney International Date published:

Related Readings